ArticleFrontiers in neurology2022
Endovascular Treatment of Large or Giant Basilar Artery Aneurysms Using the Pipeline Embolization Device: Complications and Outcomes.
Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Dissecting and partially thrombosed basilar artery aneurysm simultaneously treated with 2 different types of endovascular stents.Radiology case reports · 2026Article
- Article
- Management and long-term follow-up of basilar trunk artery aneurysms: a single center experience.Neurosurgical review · 2025Article
- Clinical Outcomes On Tubridge Flow Diverter in Treatmenting Intracranial Aneurysms: a Retrospective Multicenter Registry Study.Clinical neuroradiology · 2024Article
- Systematic Review and Meta-Analysis of Endovascular Therapy Effectiveness for Unruptured Saccular Intracranial Aneurysms.Stroke (Hoboken, N.J.) · 2024Article
- Review of current treatment modalities and clinical outcome of giant saccular aneurysms of the basilar apex.Brain & spine · 2024Review
- Long-term outcomes and dynamic changes of in-stent stenosis after Pipeline embolization device treatment of intracranial aneurysms.Journal of neurointerventional surgery · 2023Article
- Reconstructive endovascular treatment for basilar artery trunk aneurysms: complications and clinical and angiography outcomes.Journal of neurointerventional surgery · 2023Article
- A Case Report of a Giant Basilar Artery Aneurysm.Cureus · 2023Article
- Case report: Covered stent placement to treat delayed aneurysmal rupture after flow diverter-assisted coil embolization.Frontiers in neurology · 2022Article
- Use of flow diverter device in basilar artery for aneurysm treatment: Case series and literature review.Frontiers in neurology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate clinical and angiographic outcomes of Pipeline embolization device (PED) treatment of large or giant basilar artery (BA) aneurysms and examine associated factors. Methods: Clinical and angiographic data of 29 patients (18 men, 11 women) with large or giant BA aneurysms were retrospectively examined. Mean age was 44.1 ± 21.2 years (range, 30-68). Mean aneurysm size was 22.2 ± 8.3 mm (range, 12.0-40.1). Results: Mean angiographic follow-up was 18.3 ± 3.4 months (range, 4.5-60). The rate of adequate aneurysmal occlusion (O'Kelly-Marotta grade C-D) was 87%. The overall complication rate was 44.8%; most complications (84.6%) occurred in the periprocedural period. Univariable comparison of patients who did and did not develop complications showed significant differences in aneurysm size ( Conclusion: PED treatment of large or giant BA aneurysms is effective and can achieve a satisfactory long-term occlusion rate. However, the treatment complications are not negligible. Aneurysm size is the strongest predictor of perioperative complications and poor clinical outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.